Insider trades
David W. Boyer, Chief Officer of Neurocrine Biosciences NBIX, has filed 0 purchases and 24 sales on the open market. Over the past 12 months that comes to a net sale of $609K. The latest trade was on 05/26.
David W. Boyer
Chief Corp. Affairs Officer
- Company
- Neurocrine Biosciences NBIX
- First filing
- 23/02/02
- Trades
- 54 trades
- Buys / sales
- 0 / 24
- 12-month net buying
- −$609K
- Last trade
- 05/26
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 05/26 | 05/28 | 3,888 sh | $156.64 | $609,016.32 | −33.3% | |
NBIX | Open-market sale10b5-1 plan | 25/02/13 | 25/02/14 | 1,785 sh2 trades | $116.74avg. | $208,387.15 | −33.4% |
| Open-market sale10b5-1 plan | 25/02/10 | 25/02/12 | 700 sh | $118.31 | $82,817 | −25.9% | |
| Open-market sale10b5-1 plan | 25/01/31 | 25/02/04 | 1,104 sh | $152.94 | $168,845.76 | −44.6% | |
| Open-market sale10b5-1 plan | 24/10/03 | 24/10/07 | 1,295 sh | $113.66 | $147,189.7 | −77.5% | |
| Open-market sale10b5-1 plan | 24/09/13 | 24/09/17 | 3,461 sh | $121.88 | $421,826.68 | −67.4% | |
NBIX | Open-market sale10b5-1 plan | 24/02/13 | 24/02/15 | 1,811 sh2 trades | $133.08avg. | $241,001.3 | −27.0% |
NBIX | Open-market sale10b5-1 plan | 24/02/06–24/02/08 | 24/02/08 | 1,784 sh4 trades | $137.09avg. | $244,564.6 | −26.7% |
NBIX | Open-market sale10b5-1 plan | 24/01/31 | 24/02/02 | 2,096 sh2 trades | $140.80avg. | $295,114.72 | −30.0% |
| Open-market sale10b5-1 plan | 23/10/02 | 23/10/04 | 1,437 sh | $112.68 | $161,921.16 | −22.7% | |
NBIX | Open-market sale10b5-1 plan | 23/08/30 | 23/09/01 | 2,733 sh2 trades | $107.59avg. | $294,055.86 | −44.1% |
| Open-market sale10b5-1 plan | 23/08/21 | 23/08/23 | 1,600 sh | $107.41 | $171,856 | −20.5% | |
NBIX | Open-market sale | 23/02/06–23/02/08 | 23/02/08 | 25,238 sh4 trades | $102.49avg. | $2,586,696.55 | −84.1% |
| Open-market sale | 23/01/31 | 23/02/02 | 1,104 sh | $109.92 | $121,351.68 | −22.0% |